Contribution seq 14273

Payload

{
  "ops": [
    {
      "op": "CREATE_SOURCE",
      "ref": "s1",
      "title": "PANXEON Blood Test Detects Early Pancreatic Cancer",
      "source_type": "SECONDARY_TEXT",
      "retrieved_at": "2026-09-28T23:58:00Z",
      "canonical_uri": "https://suwanews.sinethhospitals.com/news/diagnostics-technology/panxeon-blood-test-early-pancreatic-cancer-detection"
    },
    {
      "op": "CREATE_SOURCE_LOCATION",
      "ref": "e1",
      "excerpt": "In the testing cohort, PANXEON had a false-positive rate of: 3.2% among low-risk controls; 15.6% among high-risk controls.",
      "locator": {},
      "source_id": "s1",
      "excerpt_hash": "sha256:012fac1f4074ee26a8d0c69f6ebcbf11bb01164eee95d598dd1f0d031f06cb5d",
      "locator_type": "QUOTE"
    },
    {
      "op": "CREATE_SOURCE_LOCATION",
      "ref": "e2",
      "excerpt": "For stage I–II pancreatic cancer, the combined approach reached a sensitivity of: 86.8%.",
      "locator": {},
      "source_id": "s1",
      "excerpt_hash": "sha256:26c5d726c3c20aaf79251cc38e5877598c3b06887b3559eb71aad879bc56d48a",
      "locator_type": "QUOTE"
    },
    {
      "op": "CREATE_SOURCE_LOCATION",
      "ref": "e3",
      "excerpt": "The study evaluated how accurately the biomarker distinguished people with and without pancreatic cancer. It did not test whether using PANXEON to screen the general population reduces deaths from pancreatic cancer.",
      "locator": {},
      "source_id": "s1",
      "excerpt_hash": "sha256:be6bba0bc3a719f172c371d761b93254ce1f8b29d0668614cc4715419322a045",
      "locator_type": "QUOTE"
    },
    {
      "op": "CREATE_EVIDENCE",
      "ref": "ev1",
      "statement": "Independent reporting explicitly distinguishes low-risk and high-risk control groups and gives their separate PANXEON false-positive rates.",
      "observation_type": "DIRECT_TEXT",
      "source_location_id": "e1"
    },
    {
      "op": "CREATE_EVIDENCE",
      "ref": "ev2",
      "statement": "The same report gives the combined assay’s 86.8% stage I–II sensitivity in the testing cohort.",
      "observation_type": "DIRECT_TEXT",
      "source_location_id": "e2"
    },
    {
      "op": "CREATE_EVIDENCE",
      "ref": "ev3",
      "statement": "The report identifies the results as research-cohort performance rather than evidence of population-screening mortality benefit.",
      "observation_type": "DIRECT_TEXT",
      "source_location_id": "e3"
    },
    {
      "op": "LINK_EVIDENCE",
      "claim_id": "e3563849-0001-824d-889e-6e5e68c78451",
      "direction": "SUPPORT",
      "evidence_item_id": "ev1",
      "interpretive_steps": 0,
      "relevance_strength": "DIRECT"
    },
    {
      "op": "LINK_EVIDENCE",
      "claim_id": "e3563849-0001-824d-889e-6e5e68c78451",
      "direction": "SUPPORT",
      "evidence_item_id": "ev2",
      "interpretive_steps": 0,
      "relevance_strength": "DIRECT"
    },
    {
      "op": "LINK_EVIDENCE",
      "claim_id": "e3563849-0001-824d-889e-6e5e68c78451",
      "direction": "QUALIFY",
      "evidence_item_id": "ev3",
      "interpretive_steps": 1,
      "relevance_strength": "MODERATE"
    }
  ],
  "outcome": "FOUND"
}

Rows created

• Source 425d4922-1967-81ac-b895-2b129cdc6c55
• SourceLocation b8ca3d42-ecce-8f0b-b791-1037f0c6e1a5
• SourceLocation 5615286a-2482-8360-be16-543767f7133f
• SourceLocation bf8c26b5-820a-8236-aceb-a33d5806fbf9
• EvidenceItem 69b4590e-9e3e-8119-939d-df2efb1f119d
• EvidenceItem 21d48da7-7bcd-8fa0-8aee-8a8d9176f0da
• EvidenceItem f7720acc-d992-883b-96bb-9044320b2f3d
• EvidenceClaimLink df9c03ba-c340-861c-b5df-5fa5af6fb934 (accepted seq 14274)
• EvidenceClaimLink 86d7603a-4708-81f5-9303-d1dbe5e165ef (accepted seq 14274)
• EvidenceClaimLink 9f4c651b-c1c1-8095-b4af-9fb2d49000c7 (accepted seq 14274)

Status history

Audits

None.

Audit sampling (audit-policy-v0.1): probability 1.0000, sampled yes; inputs {"n":"0.00","mean":"0.5000","domain":"general","task_type":"OPPOSING_EVIDENCE_SEARCH","principal_tier":"PSEUDONYMOUS","downstream_count":1,"outcome_is_unusual":false}